What Are The Optimal Patient Selection Criteria And Clinical Protocols For Long-Pulse 755 Nm Alexandrite Laser Systems In Treating Vascular Lesions?

The optimal candidates for long-pulse 755 nm alexandrite treatment are patients with superficial-to-moderately deep venous vascular lesions, vessel diameters of approximately 0.4–2.0 mm, and Fitzpatrick Skin Types I–III without an active tan. The protocol generally uses millisecond pulses, adequate epidermal cooling, and fluence adjusted to vessel size and depth. Higher-risk patients, especially those with Fitzpatrick Types IV–VI, flat light-pink lesions, or lesions near the airway, require substantially more conservative selection and treatment.

Long-pulse 755 nm alexandrite is best suited to deeper, blue or violaceous vascular lesions and selected leg telangiectasias in lightly pigmented, untanned skin. Effective treatment depends less on using the highest possible energy than on matching fluence, pulse duration, spot size, cooling, and treatment endpoint while avoiding pulse stacking.

Selecting the Right Patient and Lesion

Favor Venous and Deeper Lesions

The 755 nm wavelength penetrates approximately 2–3 mm and has relatively strong absorption by deoxygenated hemoglobin. This makes it particularly useful for deep violaceous lesions, reticular veins, nodular vascular lesions, and selected venous components of port-wine stains.

It is less predictable for very superficial, small, bright-red arterial vessels, where a vascular-specific wavelength such as pulsed-dye laser may be more appropriate.

Match Treatment to Vessel Diameter

The most suitable lower-extremity targets are generally 0.4–2.0 mm vessels, with some references extending the usable range to approximately 3.0 mm. Larger or deeper vessels may respond, but treatment becomes more painful, less predictable, and more likely to require combination therapy.

Clinical assessment should document vessel color, depth, diameter, location, and whether the lesion is flat, hypertrophic, or nodular. These features determine whether 755 nm alexandrite, another vascular laser, sclerotherapy, or a combined approach is most appropriate.

Prioritize Fitzpatrick Types I–III

Patients with Fitzpatrick Skin Types I–III, particularly without a sun tan, have the most favorable safety profile. The 755 nm wavelength is also absorbed by epidermal melanin, so darker skin increases the risk of epidermal injury, post-inflammatory hyperpigmentation, hypopigmentation, and scarring.

Fitzpatrick Types IV–VI are not automatically excluded, but treatment should be approached cautiously. Conservative test spots, strict cooling, lower starting fluence, and careful follow-up are important; in many cases, a different wavelength with less melanin absorption may offer a safer risk-benefit balance.

Screen for Factors That Increase Risk

Treatment should be deferred or reconsidered when the skin is recently tanned, inflamed, infected, or otherwise compromised. The clinician should also assess healing history, prior pigmentary reactions, tendency toward hypertrophic scarring, and medications or conditions that may alter photosensitivity or wound healing.

Patients should understand that multiple sessions may be needed and that deep vessels may develop delayed purpura or other changes before clinical clearance becomes apparent.

Building the Clinical Protocol

Establish Baseline Documentation

Photographs should be taken under consistent lighting and positioning. For leg lesions, documentation should include vessel distribution and, when clinically indicated, assessment for venous insufficiency or larger underlying veins.

The protocol should also record the device model, spot size, fluence, pulse duration, cooling settings, treatment endpoint, and adverse effects. This makes subsequent parameter adjustments more defensible and reproducible.

Use a Conservative Test Spot

A test spot is especially important for darker phototypes, recently sun-exposed skin, unusual lesions, and areas where scarring or pigment alteration would be consequential. The response should be assessed after an appropriate interval rather than relying only on the immediate appearance.

A delayed gray-to-deep-purple response can be consistent with treatment of a deeper vessel. Absence of a dramatic immediate visual change does not necessarily mean that the treatment was ineffective.

Select Pulse Duration by Vessel Characteristics

Long-pulse systems commonly operate in the 3–20 ms range. Shorter pulse durations, often below 10 ms, may be effective for smaller leg telangiectasias when paired with appropriate fluence and cooling.

Longer pulses may be useful when treating larger or deeper vessels, but the correct setting depends on the device, spot size, vessel diameter, skin type, and cooling performance. Pulse duration should not be selected independently of fluence because both affect thermal delivery and epidermal risk.

Adjust Fluence and Spot Size Together

Reported fluences span approximately 20–80 J/cm², with many protocols for resistant or deeper lesions using 25–80 J/cm². These figures are reference ranges, not universal prescriptions.

A practical device-specific relationship is to use larger spot sizes, such as 12–15 mm, with lower fluences around 25–35 J/cm², while reserving approximately 50–80 J/cm² for smaller 6–8 mm spots when clinically justified. The device manufacturer’s parameters, test-spot response, and treatment endpoint must take priority.

Use Effective Epidermal Cooling

Dynamic cryogen spray cooling or suitable contact cooling is essential when using the high fluences often required for vessel photocoagulation. Cooling protects the epidermis, reduces pain, and limits bulk thermal injury.

Cooling settings should be matched to the device and skin type. In darker skin, inadequate cooling combined with high fluence substantially increases the risk of dyspigmentation and epidermal damage.

Treat With Contiguous, Non-Overlapping Pulses

Pulses should be placed contiguously over the target while avoiding unnecessary overlap. Pulse stacking must be avoided, because repeated delivery to the same area can cause excessive epidermal heating, blistering, hyperpigmentation, or scarring.

The operator should monitor the skin continuously and reduce or stop treatment if the reaction suggests excessive epidermal injury rather than controlled vascular coagulation.

Recognizing the Treatment Endpoint

Use Vessel-Specific Clinical Endpoints

For deeper lesions, the immediate endpoint may be subtle. A transient gray discoloration followed by persistent deep purpura can indicate effective intravascular photothermal injury.

For smaller superficial vessels, visible vessel darkening, disappearance, or a controlled purpuric response may occur. The endpoint should be interpreted alongside pain, epidermal reaction, and the patient’s skin type.

Avoid Treating Immediate Clearance as the Only Goal

The absence of instant vessel disappearance does not justify increasing energy during the same session. Deep vascular injury and thrombosis may evolve over time, and aggressive escalation can convert an adequate treatment into an epidermal injury.

Follow-up should occur after the tissue response has stabilized before deciding whether to increase fluence, change pulse duration, or use another modality.

Combining Alexandrite With Other Treatments

Use Sclerotherapy for Appropriate Leg Veins

For leg telangiectasias and reticular veins, combining alexandrite sessions with sclerotherapy may improve overall vessel clearance compared with either treatment alone. Sclerotherapy is particularly relevant when the vascular network includes vessels that are too large, too deep, or otherwise poorly suited to laser photothermolysis.

The treatment sequence should be based on the vascular anatomy, the clinician’s experience, and the risk of inflammation or pigmentary change.

Consider Alexandrite for Resistant or Nodular Lesions

The 755 nm wavelength may be useful when pulsed-dye laser treatment has been ineffective or when a port-wine stain has developed deeper or nodular changes. Its deeper penetration and greater relative interaction with deoxygenated hemoglobin make it a potential option for venous-dominant components.

This is a selective indication rather than a reason to replace first-line treatment for every vascular lesion.

Understanding the Trade-offs

Higher Fluence Improves Coagulation but Raises Risk

High fluence can improve vessel photocoagulation, particularly in deeper or resistant lesions. The same increase also raises the risk of pain, purpura, epidermal injury, post-inflammatory hyperpigmentation, hypopigmentation, and scarring.

The objective is a controlled vascular endpoint with intact epidermis, not the most intense immediate skin reaction.

Darker Skin Requires a Different Risk Calculation

Because 755 nm light is strongly absorbed by melanin as well as hemoglobin, darker phototypes have less separation between target absorption and epidermal absorption. Even with cooling, the margin for error is narrower.

Conservative testing and alternative wavelengths should be considered when pigmentary complications would be unacceptable.

Flat Light-Pink Lesions May Be Poor Targets

Flat, light-pink lesions may have insufficient target contrast for safe and predictable treatment at the fluences required for deeper vascular coagulation. Using aggressive settings in this situation can produce thermal epidermal injury without adequate vessel clearance.

Lesion morphology and vascular depth should therefore guide modality selection.

Mucosal and Airway-Adjacent Lesions Need Special Precautions

Deep or mucosal vascular lesions may be treated in selected circumstances, but the consequences of edema are different from those on ordinary skin. For oral or airway-adjacent lesions, excessive photothermal treatment can produce severe localized swelling and potentially compromise the airway.

These cases require specialist assessment, appropriate airway planning, strict cooling, and conservative treatment. They should not be managed using routine leg-vein settings.

Multiple Sessions Are Usually More Realistic

Vascular clearance commonly requires more than one session, particularly for deeper lesions or extensive telangiectatic networks. Repeated treatment should be based on the clinical response and tissue recovery, not on a predetermined escalation schedule.

How to Apply This to Your Project

The safest protocol is individualized and device-specific, but the following principles provide a practical framework:

If your primary focus is small leg telangiectasias: Select untanned Fitzpatrick I–III patients with approximately 0.4–2.0 mm vessels, use millisecond pulses and appropriate fluence, apply dynamic cooling, and avoid pulse stacking.
If your primary focus is deep or violaceous lesions: Favor lesions with a clear venous or deoxygenated component, use a sufficiently long pulse and penetration-appropriate spot size, and judge success by delayed vascular response rather than immediate disappearance.
If your primary focus is maximum clearance of leg veins: Evaluate whether sclerotherapy should be combined with alexandrite treatment, particularly for larger or deeper reticular veins.
If your primary focus is treating darker phototypes: Treat only after careful risk assessment and test-spot evaluation, use conservative parameters and strict cooling, and consider a wavelength with lower epidermal melanin absorption.
If your primary focus is mucosal or airway-adjacent disease: Refer for specialist management with airway risk assessment; do not extrapolate routine cutaneous protocols to these sites.

Optimal outcomes come from selecting a venous, sufficiently deep target in appropriately pigmented skin and controlling thermal exposure with individualized parameters, effective cooling, and disciplined pulse placement.

Summary Table:

Criteria	Optimal Recommendation
Skin Types	Fitzpatrick I–III, without tan
Vessel Diameter	0.4–2.0 mm (up to 3 mm)
Lesion Type	Superficial-to-moderately deep venous, blue/violaceous
Wavelength	755 nm
Pulse Duration	3–20 ms (millisecond range)
Fluence	20–80 J/cm² (adjusted to spot size)
Spot Size	6–15 mm (larger for lower fluence)
Cooling	Dynamic cryogen or contact cooling essential
Treatment Endpoint	Transient gray discoloration, delayed purpura
Avoid	Pulse stacking, overtreating flat pink lesions
Candidates	Untanned, light skin with venous lesions

Elevate your practice with BELIS's advanced alexandrite laser systems, designed for safe and effective vascular lesion treatment. Our devices offer precise parameters and superior cooling to help you achieve optimal patient outcomes. Contact our experts today at Contact Us to learn how our medical-grade equipment can benefit your clinic or premium salon.

Menu

What are the optimal patient selection criteria and clinical protocols for long-pulse 755 nm alexandrite laser systems in treating vascular lesions?